1ZTS:BIT
Zoetis Inc
61,60 €
arrow_downward
-0,93%(-0,58) 1d
2 d’oct., 17:26:00 GMT+2 · EUR
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
NotÃcies
De fonts web i partners de notÃcies
Simply Wall Street
·
fa 21 hores
Zoetis (ZTS) Could Be 15% Undervalued Following Its 2026 Earnings Outlook Cut
ad-hoc-news.de
·
fa 1 dia
Goldman Sachs starts coverage: Zoetis stock gets a USD 74 target
Perfil
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia